Sign in or create an account to add this stock to your watchlist.
About MediWound (NASDAQ:MDWD)
MediWound Ltd., an integrated biopharmaceutical company, focuses on developing, manufacturing, and commercializing novel therapeutics products to address unmet needs. It markets NexoBrid, a biopharmaceutical product for the removal of eschar, a dead or damaged tissue in adults with deep partial- and full-thickness thermal burns in the European Union, Israel, and Argentina. The company also develops EscharEx, which is in Phase II clinical trials for the debridement of chronic and other hard-to-heal wounds. MediWound Ltd. was founded in 2000 and is headquartered in Yavne, Israel.
Industry, Sector and Symbol
Industry Medicinals & botanicals
Sub-IndustryN/A
SectorMedical
SymbolNASDAQ:MDWD
CUSIPN/A
Phone972-77-971-4100
Debt
Debt-to-Equity RatioN/A
Current Ratio6.07
Quick Ratio5.75
Price-To-Earnings
Trailing P/E Ratio-10.73
Forward P/E Ratio-8.75
P/E GrowthN/A
Sales & Book Value
Annual Sales$2.50 million
Price / Sales71.95
Cash FlowN/A
Price / CashN/A
Book Value$0.19 per share
Price / Book35.00
Profitability
EPS (Most Recent Fiscal Year)($0.62)
Net Income$-22,140,000.00
Net Margins-904.12%
Return on Equity-226.62%
Return on Assets-36.64%
Miscellaneous
Employees72
Outstanding Shares27,050,000
MediWound (NASDAQ:MDWD) Frequently Asked Questions
What is MediWound's stock symbol?
MediWound trades on the NASDAQ under the ticker symbol "MDWD."
How were MediWound's earnings last quarter?
MediWound (NASDAQ:MDWD) released its quarterly earnings results on Thursday, May, 10th. The biopharmaceutical company reported ($0.17) earnings per share (EPS) for the quarter, hitting the consensus estimate of ($0.17). The biopharmaceutical company earned $0.52 million during the quarter, compared to the consensus estimate of $0.57 million. MediWound had a negative return on equity of 226.62% and a negative net margin of 904.12%. View MediWound's Earnings History.
When is MediWound's next earnings date?
What price target have analysts set for MDWD?
5 equities research analysts have issued 12-month price objectives for MediWound's stock. Their predictions range from $8.00 to $14.00. On average, they anticipate MediWound's stock price to reach $10.00 in the next year. View Analyst Ratings for MediWound.
Who are some of MediWound's key competitors?
Some companies that are related to MediWound include Foamix Pharmaceuticals (FOMX), Chromadex (CDXC), Natural Alternatives International (NAII), Mannatech (MTEX), Pharmacyte Biotech (PMCB), China Jo-Jo Drugstores (CJJD), GLG Life Tech (GLGLF), Cyanotech (CYAN), ImmuDyne (IMMD), FitLife Brands (FTLF), True Drinks (TRUU), Nutra Pharma (NPHC), Tauriga Sciences (TAUG), Entia Biosciences (ERGO) and Rock Creek Pharmaceutical (RCPIQ).
Who are MediWound's key executives?
MediWound's management team includes the folowing people:
- Mr. Gal Cohen B.Sc. MBA, Pres & CEO (Age 45)
- Prof. Lior Rosenberg M.D., Co-Founder & Chief Medical Technology Officer (Age 72)
- Mr. Sharon Malka CPA, MBA, Chief Financial & Operation Officer (Age 46)
- Mr. Carsten Henke B.Sc., Chief Commercial Officer of Europe (Age 52)
- Dr. Ety Klinger Ph.D., MBA, Chief R&D Officer (Age 56)
Has MediWound been receiving favorable news coverage?
News coverage about MDWD stock has trended positive recently, Accern Sentiment reports. The research group identifies negative and positive news coverage by monitoring more than 20 million blog and news sources in real time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. MediWound earned a coverage optimism score of 0.30 on Accern's scale. They also assigned headlines about the biopharmaceutical company an impact score of 44.00 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the company's share price in the next few days.
Who are MediWound's major shareholders?
MediWound's stock is owned by many different of institutional and retail investors. Top institutional investors include Migdal Insurance & Financial Holdings Ltd. (7.68%) and Wells Fargo & Company MN (0.45%). View Institutional Ownership Trends for MediWound.
Which institutional investors are selling MediWound stock?
Which institutional investors are buying MediWound stock?
How do I buy shares of MediWound?
Shares of MDWD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is MediWound's stock price today?
One share of MDWD stock can currently be purchased for approximately $6.65.
How big of a company is MediWound?
MediWound has a market capitalization of $181.22 million and generates $2.50 million in revenue each year. The biopharmaceutical company earns $-22,140,000.00 in net income (profit) each year or ($0.62) on an earnings per share basis. MediWound employs 72 workers across the globe.
How can I contact MediWound?
MediWound's mailing address is 42 HAYARKON STREET, YAVNE L3, 8122745. The biopharmaceutical company can be reached via phone at 972-77-971-4100 or via email at [email protected]
MarketBeat Community Rating for MediWound (MDWD)
MarketBeat's community ratings are surveys of what our community members think about MediWound and other stocks. Vote "Outperform" if you believe MDWD will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MDWD will underperform the S&P 500 over the long term. You may vote once every thirty days.
MediWound (NASDAQ:MDWD) Price Target and Consensus Rating
(How are Consensus Ratings Calculated?) MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
5 Wall Street analysts have issued ratings and price targets for MediWound in the last 12 months. Their average twelve-month price target is $10.00, suggesting that the stock has a possible upside of 50.38%. The high price target for MDWD is $14.00 and the low price target for MDWD is $8.00. There are currently 5 buy ratings for the stock, resulting in a consensus rating of "Buy."
| Today | 30 Days Ago | 90 Days Ago | 180 Days Ago |
| Consensus Rating: | Buy | Buy | Buy | Buy |
| Consensus Rating Score: | 3.00 | 3.00 | 3.00 | 3.00 |
| Ratings Breakdown: | 0 Sell Rating(s)
0 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s) | 0 Sell Rating(s)
0 Hold Rating(s)
6 Buy Rating(s)
0 Strong Buy Rating(s) | 0 Sell Rating(s)
0 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s) | 0 Sell Rating(s)
0 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s) |
| Consensus Price Target: | $10.00 | $9.8333 | $9.80 | $9.80 |
| Price Target Upside: | 50.38% upside | 82.10% upside | 106.32% upside | 113.04% upside |
MediWound (NASDAQ:MDWD) Consensus Price Target History
MediWound (NASDAQ:MDWD) Analyst Ratings History
Show:
(Data available from 5/26/2016 forward)
MediWound (NASDAQ:MDWD) Dividend History by Quarter
| Announced | Period | Amount | Yield | Ex-Dividend Date | Record Date | Payable Date |
|---|
(Data available from 1/1/2013 forward)
MediWound (NASDAQ MDWD) Insider Trading and Institutional Ownership History
Institutional Ownership Percentage: 32.78%
MediWound (NASDAQ MDWD) Insider Trading History
| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Shares Held After Transaction | Details |
|---|
(Data available from 1/1/2013 forward)
MediWound (NASDAQ MDWD) News Headlines
| Source: |
|
| Date | Headline |
|---|
 | MediWound (MDWD) versus ChromaDex (CDXC) Head-To-Head Survey
www.americanbankingnews.com - May 22 at 9:40 AM |
| Zacks: Analysts Expect MediWound (MDWD) Will Announce Quarterly Sales of $970,000.00
www.americanbankingnews.com - May 22 at 2:50 AM |
| -$0.19 EPS Expected for MediWound (MDWD) This Quarter
www.americanbankingnews.com - May 20 at 5:16 PM |
| MediWound (MDWD) and True Drinks (TRUU) Critical Comparison
www.americanbankingnews.com - May 14 at 5:16 PM |
 | MediWound's (MDWD) CEO Gal Cohen on Q1 2018 Results - Earnings Call Transcript
seekingalpha.com - May 12 at 5:35 PM |
| MediWound (MDWD) Releases Earnings Results, Hits Expectations
www.americanbankingnews.com - May 12 at 2:40 PM |
| Comparing True Drinks (TRUU) & MediWound (MDWD)
www.americanbankingnews.com - May 12 at 1:49 PM |
| MediWound (MDWD) Raised to "Sell" at ValuEngine
www.americanbankingnews.com - May 11 at 9:23 PM |
 | Edited Transcript of MDWD earnings conference call or presentation 10-May-18 12:30pm GMT
finance.yahoo.com - May 11 at 8:49 AM |
| MediWound (MDWD) Given a $14.00 Price Target by Oppenheimer Analysts
www.americanbankingnews.com - May 10 at 5:58 PM |
 | BRIEF-MediWound Reports Q1 Loss Per Share Of $0.17
www.reuters.com - May 10 at 8:38 AM |
| MediWound: 1Q Earnings Snapshot
finance.yahoo.com - May 10 at 8:38 AM |
| MediWound Reports First Quarter 2018 Financial Results
finance.yahoo.com - May 10 at 8:38 AM |
| Financial Analysis: True Drinks (TRUU) versus MediWound (MDWD)
www.americanbankingnews.com - May 7 at 9:14 AM |
| MediWound (MDWD) Set to Announce Earnings on Thursday
www.americanbankingnews.com - May 5 at 10:51 AM |
| $570,000.00 in Sales Expected for MediWound (MDWD) This Quarter
www.americanbankingnews.com - May 5 at 4:36 AM |
| MediWound (MDWD) Receives Average Recommendation of "Buy" from Brokerages
www.americanbankingnews.com - May 5 at 1:33 AM |
| MediWound to Host First Quarter 2018 Financial Results Conference Call on May 10 at 8:30 a.m. Eastern Time
finance.yahoo.com - May 4 at 5:17 PM |
| -$0.17 Earnings Per Share Expected for MediWound (MDWD) This Quarter
www.americanbankingnews.com - May 3 at 5:32 AM |
| MediWound (MDWD) Cut to "Sell" at Zacks Investment Research
www.americanbankingnews.com - April 19 at 5:50 PM |
| Analysts Anticipate MediWound (MDWD) Will Post Quarterly Sales of $570,000.00
www.americanbankingnews.com - April 18 at 4:32 AM |
| MediWound (MDWD) Expected to Post Earnings of -$0.17 Per Share
www.americanbankingnews.com - April 16 at 3:24 AM |
| MediWound (MDWD) Upgraded by Zacks Investment Research to "Hold"
www.americanbankingnews.com - April 14 at 1:59 PM |
| Zacks Investment Research Lowers MediWound (MDWD) to Sell
www.americanbankingnews.com - April 12 at 10:46 PM |
| MediWound (MDWD) Given Average Rating of "Buy" by Analysts
www.americanbankingnews.com - April 10 at 1:41 AM |
| MediWound’s NexoBrid® to be Highlighted in Presentations at the American Burn Association 50th Annual Meeting Being Held on April 10-13, 2018 in Chicago
finance.yahoo.com - April 9 at 8:40 AM |
| Analyzing Actelion (ALIOF) & MediWound (MDWD)
www.americanbankingnews.com - April 9 at 5:13 AM |
| Analyzing MediWound (MDWD) & Foamix Pharmaceuticals (FOMX)
www.americanbankingnews.com - April 7 at 7:28 PM |
| Oppenheimer Analysts Give MediWound (MDWD) a $10.00 Price Target
www.americanbankingnews.com - April 6 at 10:54 PM |
| $570,000.00 in Sales Expected for Mediwound Ltd (MDWD) This Quarter
www.americanbankingnews.com - April 1 at 4:42 AM |
| -$0.17 EPS Expected for Mediwound Ltd (MDWD) This Quarter
www.americanbankingnews.com - March 30 at 9:04 AM |
| Oppenheimer Boosts Mediwound (MDWD) Price Target to $12.00
www.americanbankingnews.com - March 24 at 12:17 PM |
| Zacks Investment Research Upgrades Mediwound (MDWD) to "Hold"
www.americanbankingnews.com - March 23 at 10:46 PM |
| Mediwound Ltd to Post Q1 2018 Earnings of ($0.25) Per Share, Jefferies Group Forecasts (MDWD)
www.americanbankingnews.com - March 22 at 8:45 AM |
| Oppenheimer Analysts Decrease Earnings Estimates for Mediwound Ltd (MDWD)
www.americanbankingnews.com - March 22 at 8:42 AM |
| Research Analysts Set Expectations for Mediwound Ltd's Q1 2018 Earnings (MDWD)
www.americanbankingnews.com - March 22 at 8:42 AM |
| Mediwound Ltd (MDWD) Expected to Earn Q1 2019 Earnings of ($0.18) Per Share
www.americanbankingnews.com - March 21 at 10:58 AM |
| Mediwound Ltd (MDWD) Forecasted to Post Q4 2018 Earnings of ($0.21) Per Share
www.americanbankingnews.com - March 21 at 10:26 AM |
| Mediwound (MDWD) Given New $8.00 Price Target at Wells Fargo
www.americanbankingnews.com - March 20 at 11:12 AM |
| Edited Transcript of MDWD earnings conference call or presentation 19-Mar-18 12:30pm GMT
finance.yahoo.com - March 20 at 8:45 AM |
| Mediwound (MDWD) Issues Earnings Results, Beats Estimates By $0.08 EPS
www.americanbankingnews.com - March 19 at 1:48 PM |
 | MediWound Ltd. to Host Earnings Call
www.baystreet.ca - March 19 at 8:37 AM |
| Mediwound Ltd (MDWD) Receives Consensus Rating of "Hold" from Analysts
www.americanbankingnews.com - March 16 at 1:54 AM |
| MediWound (MDWD) Presents At 38th Annual Cowen and Company Healthcare Conference - Slideshow
seekingalpha.com - March 15 at 5:54 PM |
| $650,000.00 in Sales Expected for Mediwound Ltd (MDWD) This Quarter
www.americanbankingnews.com - March 15 at 2:13 PM |
| Mediwound (MDWD) to Release Quarterly Earnings on Monday
www.americanbankingnews.com - March 14 at 12:20 PM |
| MediWound to Host Fourth Quarter and Fiscal Year 2017 Financial Results Conference Call on March 19 at 8:30 a.m. Eastern Time
finance.yahoo.com - March 13 at 7:06 PM |
| MediWound to Present at Two Investor Conferences
finance.yahoo.com - March 8 at 6:22 PM |
| Mediwound (MDWD) Cut to "Strong Sell" at ValuEngine
www.americanbankingnews.com - March 4 at 3:00 PM |
| Mediwound Ltd (MDWD) Expected to Announce Quarterly Sales of $650,000.00
www.americanbankingnews.com - February 26 at 7:24 AM |
MediWound (NASDAQ:MDWD) SEC Filings
This page is loading this company's SEC Filings. Please wait...
MediWound (NASDAQ:MDWD) Income Statement, Balance Sheet and Cash Flow Statement
MediWound (NASDAQ MDWD) Stock Chart for Saturday, May, 26, 2018
Loading chart…
